RSSLetters to the Editor

Letter to the Editor

Letter to the Editor

| August 1, 2018

Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to the content of this article. Brassiere Clasps are a Source of Nickel Exposure  Dear Editor: Nickel sensitization has been repeatedly associated with piercings and jewelry exposure in both women and children.1 We report a case of an allergic reaction to […]

Continue Reading

Letter to the Editor

Letter to the Editor

| July 1, 2018

Regarding Statement from FDA Commissioner on New FDA Actions to Keep Consumers Safe from the Harmful Effects of Sun Exposure, and Ensure the Long-term Safety and Benefits of Sunscreens Dear Editor: Ferndale Healthcare, Inc., would like to comment as the distributors of Heliocare capsules, on the “Statement from the FDA Commissioner Scott Gottlieb, M.D. on […]

Continue Reading

Letter to the Editor: Be Aware: Dupilumab Use

Letter to the Editor: Be Aware: Dupilumab Use

| March 1, 2018

by Linda S. Marcus, MD Dr. Marcus is the Director of Dermatology Valley Hospital in Ridgewood, New Jersey. Funding/financial disclosures: The author has no conflicts of interest relevant to the content of this letter. No funding was received for the preparation of this letter. Dear Editor: Dupilumab, a monoclonal antibody that attaches to the alpha subunit of […]

Continue Reading

Ingenol Mebutate for the Treatment of Intraepidermal Squamous Cell Carcinoma

Ingenol Mebutate for the Treatment of Intraepidermal Squamous Cell Carcinoma

| July 1, 2017

by Efstathios Rallis, MD, PhD; Angeliki Liakopoulou, MD; Constantinos Christodoulopoulos, MD Department of Dermatology, Veterans Administration Hospital (NIMTS), Athens, Greece Funding: No funding was received for the preparation of this letter. Disclosures: The authors have no conflicts of interest relevant to the content of this letter. J Clin Aesthet Dermatol. 2017;10(7):12–13 Dear Editor: Squamous cell carcinoma (SCC) […]

Continue Reading

Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma

Letter to the Editor: Topical Anti-Estrogen Therapy To Treat Melasma

| June 1, 2017

by Philip R. Cohen, MD Dear Editor: I read with interest the recent report by Snyder et al[1] describing melasma associated with the application of a topical estrogen cream. The development of melasma is multifactorial and female sex hormones have been implicated in the pathogenesis of this condition.[2] Estrogen receptor expression is increased in melasma […]

Continue Reading

Picosecond Lasers: A New and Emerging Therapy for Skin of Color, Minocycline-induced Pigmentation, and Tattoo Removal

| March 1, 2017

Jeannette Jakus, MD, MBA Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York Ajay Kailas, BS University of Central Florida College of Medicine, Orlando, Florida Author correspondence: Ajay Kailas; E-mail: ajay.kailas@Knights.ucf.edu Disclosure: The authors report no relevant conflicts of interest. J Clin Aesthet Dermatol. 2017;10(3):14–15  DEAR EDITOR: In 2012, the United States Food and […]

Continue Reading

How Confident Should We Be?

| August 1, 2015

Dear Editor: Winkelmann et al[1] presented evidence on the usefulness of multispectral digital skin lesion analysis (MelaFind®; MELA Sciences, Inc.) as an aid in evaluating pigmented lesions (PLs) that have one or more clinical or historical characteristics of melanoma in community-based practice.[2–4] Among 137 lesions selected for biopsy, all 21 lesions with a negative test […]

Continue Reading